JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McEwen, D. G.
Right arrow Articles by Ornitz, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McEwen, D. G.
Right arrow Articles by Ornitz, D. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 9, 5349-5357, February 27, 1998

Regulation of the Fibroblast Growth Factor Receptor 3 Promoter and Intron I Enhancer by Sp1 Family Transcription Factors

Donald G. McEwen and David M. Ornitz

From the Department of Molecular Biology and Pharmacology, Washington University Medical School, St. Louis, Missouri 63110

Fibroblast growth factor receptor 3 (FGFR3) has a complex spatial and temporal pattern of expression and is essential for the normal development of a diverse set of tissues. Recently, mutations have been identified in FGFR3 that result in constitutive tyrosine kinase activity and cause a number of different human skeletal disorders. To examine the regulatory mechanisms governing FGFR3 expression, the promoter for the FGFR3 gene was identified and characterized. It resides in a CpG island, which encompasses the 5' end of the FGFR3 gene and lacks classical cis-regulatory motifs. As little as 100 base pairs of sequence 5' to the initiation site can confer a 20-40-fold increase in transcriptional activity upon a promoter-less vector. The transcriptional activity of these cis-regulatory sequences is further stimulated by elements found within the first intron. Mapping of the enhancer activity found within intron I identified two purine-rich sequence motifs between +340 and +395. Electrophoretic mobility shift assays demonstrated that sequences within this region bind members of the Sp1 family of transcription factors. In a background lacking Sp1-like activity, we demonstrate that Sp1 can enhance transcription of the minimal promoter (which contains five classical Sp1 sites), whereas both Sp1 and Sp3 can enhance transcription through the elements found in intron I. Although these transcription factors are ubiquitously expressed, we demonstrate that the sequences between -220 and +609 of the FGFR3 gene are sufficient to promote the tissue-specific expression of a reporter gene in transgenic mice.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
J. W. Shin, M. Min, F. Larrieu-Lahargue, X. Canron, R. Kunstfeld, L. Nguyen, J. E. Henderson, A. Bikfalvi, M. Detmar, and Y.-K. Hong
Prox1 Promotes Lineage-specific Expression of Fibroblast Growth Factor (FGF) Receptor-3 in Lymphatic Endothelium: A Role for FGF Signaling in Lymphangiogenesis
Mol. Biol. Cell, February 1, 2006; 17(2): 576 - 584.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. I. Reinhold, D. G. McEwen, and M. C. Naski
Fibroblast Growth Factor Receptor 3 Gene: Regulation by Serum Response Factor
Mol. Endocrinol., January 1, 2004; 18(1): 241 - 251.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Yu, S. L. Asa, R. J. Weigel, and S. Ezzat
Pituitary Tumor AP-2{alpha} Recognizes a Cryptic Promoter in Intron 4 of Fibroblast Growth Factor Receptor 4
J. Biol. Chem., May 23, 2003; 278(22): 19597 - 19602.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. K. Rao, S. Maiti, H. N. Ananthaswamy, and M. F. Wilkinson
A Highly Active Homeobox Gene Promoter Regulated by Ets and Sp1 Family Members in Normal Granulosa Cells and Diverse Tumor Cell Types
J. Biol. Chem., July 12, 2002; 277(29): 26036 - 26045.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Yu, S. L. Asa, and S. Ezzat
Fibroblast Growth Factor Receptor 4 Is a Target for the Zinc-Finger Transcription Factor Ikaros in the Pituitary
Mol. Endocrinol., May 1, 2002; 16(5): 1069 - 1078.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Parakati and J. X. DiMario
Sp1- and Sp3-mediated Transcriptional Regulation of the Fibroblast Growth Factor Receptor 1 Gene in Chicken Skeletal Muscle Cells
J. Biol. Chem., March 8, 2002; 277(11): 9278 - 9285.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
H Hayashi, A Ishisaki, M Suzuki, and T Imamura
BMP-2 augments FGF-induced differentiation of PC12 cells through upregulation of FGF receptor-1 expression
J. Cell Sci., January 4, 2001; 114(7): 1387 - 1395.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Yu, A. B. Herr, G. Waksman, and D. M. Ornitz
Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome
PNAS, December 19, 2000; 97(26): 14536 - 14541.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
Z. Vajo, C. A. Francomano, and D. J. Wilkin
The Molecular and Genetic Basis of Fibroblast Growth Factor Receptor 3 Disorders: The Achondroplasia Family of Skeletal Dysplasias, Muenke Craniosynostosis, and Crouzon Syndrome with Acanthosis Nigricans
Endocr. Rev., February 1, 2000; 21(1): 23 - 39.
[Abstract] [Full Text]


Home page
Hum Mol GenetHome page
O. Segev, I. Chumakov, Z. Nevo, D. Givol, L. Madar-Shapiro, Y. Sheinin, M. Weinreb, and A. Yayon
Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3G380R transgenic mice
Hum. Mol. Genet., January 22, 2000; 9(2): 249 - 258.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. SUSINI, G. VAN HAASTEREN, S. LI, M. PRENTKI, and W. SCHLEGEL
Essentiality of intron control in the induction of c-fos by glucose and glucoincretin peptides in INS-1 {beta}-cells
FASEB J, January 1, 2000; 14(1): 128 - 136.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. G. McEwen, R. P. Green, M. C. Naski, D. A. Towler, and D. M. Ornitz
Fibroblast Growth Factor Receptor 3 Gene Transcription Is Suppressed by Cyclic Adenosine 3',5'-Monophosphate. IDENTIFICATION OF A CHONDROCYTIC REGULATORY ELEMENT
J. Biol. Chem., October 22, 1999; 274(43): 30934 - 30942.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Gemel, C. Jacobsen, and C. A. MacArthur
Fibroblast Growth Factor-8 Expression Is Regulated by Intronic Engrailed and Pbx1-binding Sites
J. Biol. Chem., February 26, 1999; 274(9): 6020 - 6026.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.